News
-
-
-
COMMUNIQUÉ DE PRESSE
CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test
CorDx receives FDA Emergency Use Authorization for Tyfast Flu A/B & COVID-19 Multi-Target Rapid Test. The 3-in-1 multiplex test detects and distinguishes between Flu A, Flu B, and COVID-19, delivering results in 10 minutes -
COMMUNIQUÉ DE PRESSE
CorDx is Expected to Launch Groundbreaking 10-Minute Solution for Distinguishing COVID-19 and Flu A/B as Respiratory Cases Surge Across the U.S.
CorDx has submitted its application for its CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test to the FDA. The 10-minute test aims to distinguish COVID-19, influenza A, and influenza B nucleocapsid protein antigens, providing a critical diagnostic solution for rising respiratory infections
